The present invention relates to semiconductor devices and methods of fabrication thereof, and more specifically to semiconductor devices with dopant migration suppression and methods of fabrication thereof.
In certain semiconductor devices, a structure is required in which a highly doped layer is disposed adjacent to a layer with a substantially lower doping. In certain cases, this arrangement can be problematic as such structures are potentially susceptible to dopant migration, via diffusion and other mechanisms. For example, when a first layer of silicon doped with boron (B) is formed adjacent to and located underneath a second layer of silicon that is undoped or has a significantly lower B doping concentration than the first layer, unwanted migration of B into the second layer can occur when a thermal treatment is applied during fabrication of the semiconductor device. Similar results have been observed for other dopants in silicon, such as phosphorus (P) and arsenic (As). As a result, the abrupt doping transition between differentially doped layers may be degraded or compromised by subsequent thermal processing. In a worst case, the dopant could diffuse completely through the second layer, altering the undoped nature of the second layer in its entirety. In either case, the electrical characteristics of the semiconductor device can be significantly altered when dopant migration occurs.
In an effort to avoid migration of highly mobile dopants, into undoped regions, development efforts have primarily focused on: (1) reducing the thermal budget during semiconductor device manufacturing processes and (2) the implantation of additional species to form blocking regions to inhibit the migration of dopants. For example, carbon (C) implants activated into substitutional lattice sites (such as by first performing a pre-amorphization followed by C implantation and recrystallization anneal) have been utilized to suppress migration of B and P in silicon.
Both of these efforts (lower thermal budgets and migration inhibitors) have met with some success, but still have drawbacks. With respect to thermal budget reductions, at least some thermal treatments will always be required and therefore the amount of thermal budget reduction is always limited. Additionally, variations in the manufacturing process can limit the effectiveness of the reduced thermal budget. In particular, defects and interstitial/vacancy pairs generated during normal semiconductor device processing can result in migration, even when a lower thermal budget is applied. Moreover, even if thermal budgets are accurately controlled, small amounts of unwanted dopant diffusion can still have a pronounced effect on devices with reduced dimensions or devices designed with low doping concentrations. In addition, some thermal steps can simply lose effectiveness if the temperature is lowered beyond a critical minimum value.
With respect to ion implantation of a migration inhibitor such as carbon, one potential issue is that there can be inaccuracies in the placement of the carbon species, resulting in some dopants being placed in undesirable locations or atoms missing from locations where the dopant diffusion protection is needed. As a result, some migration can occur due to the ineffectiveness of the ion implantation process leading to the imperfect placement of the species intended to suppress migration. Further, ion implantation processes can introduce additional contaminating impurities into the semiconductor device and additional implant damage. Either of these can adversely affect device performance. Moreover, the extra implantation steps can introduce additional costs to the manufacturing process.
In view of the foregoing, there is a need for an alternate approach for suppressing dopant migration in semiconductor devices.
Embodiments are described with reference to the attached figures, wherein like reference numerals are used throughout the figures to designate similar or equivalent elements. The figures are not drawn to scale and they are provided merely to illustrate the embodiments. It should be understood that numerous specific details, relationships, and methods are set forth to provide a full understanding of the embodiments. One having ordinary skill in the relevant art, however, will readily recognize that embodiments can be practiced without one or more of the specific details or with other methods. In other instances, well-known structures or operations are not shown in detail to avoid obscuring the embodiments. Embodiments are not limited by the illustrated ordering of acts or events, as some acts may occur in different orders and/or concurrently with other acts or events. Furthermore, not all illustrated acts or events are required to implement a methodology in accordance with the embodiments.
As noted above, dopant migration is a significant concern in various types of semiconductor devices that include low doped (or undoped) regions abutting highly doped regions. In such devices, electrical characteristics may be dependent on the formation of a sufficiently abrupt transition of dopants between the regions. One example of such a semiconductor device is the deeply depleted channel (DDC) transistor device.
DDC transistors are formed, for example, by forming a doped region in a well for CMOS devices by forming a heavily doped screen layer (5×1018 atoms/cm3 to 1×1020 atoms/cm3). This can be followed by formation of a substantially undoped (that is, a material into which electrically modifying dopants are not purposely introduced) blanket epitaxial layer (<5×1017 atoms/cm3) deposited over the screen layer, extending across multiple die and transistor die blocks.
Details regarding exemplary DDC transistor structures are more completely described in U.S. patent application Ser. No. 12/708,497 titled “ELECTRONIC DEVICES AND SYSTEMS, AND METHODS FOR MAKING AND USING THE SAME” and filed Feb. 18, 2010, U.S. patent application Ser. No. 12/971,884 titled “LOW POWER SEMICONDUCTOR TRANSISTOR STRUCTURE AND METHOD OF FABRICATION THEREOF” and filed Dec. 17, 2010, U.S. patent application Ser. No. 12/971,955 titled “TRANSISTOR WITH THRESHOLD VOLTAGE SET NOTCH AND METHOD OF FABRICATION THEREOF” and filed Dec. 17, 2010, U.S. patent application Ser. No. 12/895,785 titled “ADVANCED TRANSISTORS WITH THRESHOLD VOLTAGE SET DOPANT STRUCTURES” and filed Sep. 30, 2010, and U.S. patent application Ser. No. 12/895,813 titled “ADVANCED TRANSISTORS WITH PUNCH THROUGH SUPPRESSION” and filed Sep. 30, 2010, the disclosures of which are hereby incorporated by reference in their entirety.
Although the various embodiments will be described primarily with respect to DDC transistor devices, the various embodiments are not limited in this regard. That is, the various processes, structures and methods described herein are equally applicable to any other types of semiconductor device structures in which a highly doped region abuts a low doped or substantially undoped region, and there is the potential for migration from the doped region to the undoped region. Examples of devices designed in this manner are, super steep retrograde well devices and other depleted channel devices, or any device channel having heavily doped regions in contact with moderately doped to highly doped regions (such as traditional transistors with LDD or S/D implants adjacent to channel regions).
In depleted channel processes, the heavily doped region, which is called “well”, is typically formed via implantation of dopants. The P-well typically uses B doping. Boron migration issues are typically managed via implantation of C and careful management of thermal budget. In the case of a DDC transistor, an exemplary process flow for forming the screen regions for the DDC NMOS device can begin with B implants into the P-well for the NMOS device regions. These implants are followed by a germanium (Ge) pre-amorphization implant into the NMOS device regions at an energy of about 20 keV to 60 keV and at a dose of about 1×1014 to 1×1015 atoms/cm2. This Ge implant is then followed by a carbon (C) implant into the NMOS device regions at about 2 keV to 7 keV at a dose of about 1×1014 atoms/cm2 to 1×1015 atoms/cm2. Recrystallization anneal(s) are carried out. Separately, screen implants into the N-well for the DDC PMOS device regions, for instance, Sb or As, can be applied.
After at least the DDC NMOS implants are completed, an anneal process can be performed. The anneal process serves two purposes. First, the anneal process provides for recrystallization of the portion of the substrate amorphized by the Ge implants. This recrystallization results in at least some of the implanted C being integrated into the recrystallized substrate substitutionally. The substitutional C, in turn, prevents migration of the B atoms. Second, the anneal process serves to activate the implanted dopants for the DDC device.
The DDC process flow then continues, preferably with the formation of the substantially undoped blanket epitaxial silicon, formation of isolation features, formation of transistors and other devices thereon, and formation of interconnect features.
While the process flow above does provide some suppression of B migration in DDC structures and depleted channel structures, the reliance on an ion implantation-based process has several drawbacks. First, variations in the implant processes and numerous masking steps can result in an imperfect placement of the B and C implants, and their resulting profiles in the recrystallized substrate. For example, the implanted C region may be located below the layer of the implanted B atoms, rendering the C ineffective to prevent upward migration of B.
Second, although the anneal process following Ge pre-amorphization is intended to provide recrystallization of the substrate, such a process may not provide 100% recrystallization of the amorphized and mechanically damaged portions of the substrate. As a result, any defects remaining in the substrate can create leakage paths and reduce device yield. Additionally, such defects may provide migration paths for the B and other dopants into the epitaxial silicon layer as well as providing a source of interstitials and vacancies which can result in increased dopant diffusion coefficients for a given thermal budget.
Finally, as noted above, implant processes are well-known for introducing additional impurities. Such impurities can degrade performance and consequently reduce yields.
In view of the limitations of conventional migration suppression techniques, the various embodiments described below are directed to a process flow for suppressing dopant migration for semiconductor devices that consist of substantially undoped or low doped regions formed on a highly doped substrate. In particular, a process flow in accordance with the various embodiments provides for forming at least a portion of the highly doped regions by epitaxially depositing a layer of semiconductor material on the substrate that incorporates the electrically active dopant species, that is, via in-situ doping of the semiconductor material with the dopant species of concern. For example, in the case of a depleted channel device, this process can involve depositing a layer of B-doped silicon sufficient to form the well on the NMOS device. For the DDC device, this process can include depositing a layer of B-doped silicon with sufficient dopants to form the well and screen region for DDC devices. The advantage of such a configuration is that diffusion of such dopants is limited. In general, in the case of implanted dopants, diffusion is primarily due to the presence of point defects, self-interstitials, and vacancies in the semiconductor material that enhance the diffusivity of dopants such as boron and phosphorus. These “transient enhanced diffusion (TED) mechanisms” allow dopant atoms to more easily traverse the lattice of the semiconductor material during annealing.
The practical result of in-situ doping is that since the dopants are already incorporated into the semiconductor material, an activation anneal for such dopants is not needed. Also, in-situ doping can eliminate many of the point defects that result in TED. Further, even if some additional implants of a same conductivity type are still required to tune the device characteristics, the dopants provided in-situ will be less likely to diffuse during subsequent anneal processes. Therefore, the amount of the dopant available for diffusing into an adjacent undoped or low-doped layer is reduced compared with an all-implant method for introducing dopants into the substrate. An exemplary in-situ process is described below in greater detail with respect to
As shown in
Optionally, the deposition of the B-doped Si epi 204 can be preceded by an anti-punchthrough (APT) implant into the surface of substrate 202. For example, in the case of a Si-based DDC device, an NMOS APT implant can be provided by implanting B at an energy of about 10 keV to 30 keV at a dose of about 5×1012 atoms/cm2 to 5×1013 atoms/cm2. The B-doped Si epi 204 can then be formed.
In one embodiment, the B-doped Si epi 204 is formed by depositing a blanket layer by way of an epitaxial silicon process. The B doping can be selected to provide an appropriate doping level to define a heavily doped screen region for the P-well side of a to-be-formed device. In DDC embodiments, a B doping concentration between about 5×1018 atoms/cm3 and about 1×1020 atoms/cm3 can be provided, the particular doping concentration selected based upon desired device electrical characteristics of threshold voltage, junction leakage and other parametric considerations. In DDC embodiments, a B-doped Si epi layer of less than 10 nm can be formed, however, the thickness can be as high as 30 nm or more in some embodiments. Such a layer can be deposited using an epitaxial growth process that includes a boron doping source to provide the boron in-situ doping. For example, in particular embodiments, a chemical vapor deposition (CVD) process can be used, where B is provided by way of a suitable precursor gas, such as diborane; while disilane, silane, or dichlorosilane may be selected as the silicon precursor. In one particular embodiment, the epitaxial growth process can utilize processing temperatures of approximately 700C to 900C at a reduced pressure, for instance, 20 Torr.
Although the exemplary embodiments refer primarily to the forming of silicon-comprising layers with in situ B-doping, the various embodiments are not limited in this regard. In other embodiments, the first epitaxial layer can be doped in-situ with another type of electrically active dopant. For example, in the case of silicon-comprising materials, P can be incorporated in-situ in a similar manner as described herein.
Referring back to
Optionally, as shown in
For instance, the process may begin with a boron (B) anti-punchthrough implant (if not performed prior to formation of B-doped Si epi 204) at an energy of about 10 keV to 30 keV at a dose of about 5×1012 atoms/cm2 to 5×1013 atoms/cm2, as well as a Boron implant at an energy of about 2 keV to 10 keV at a dose of about 1×1012 atoms/cm2 to 1×1014 atoms/cm2. Combined with the dopants already incorporated into the B-doped Si epi 204, such conditions will be generally suitable for the formation of DDC NMOS low Vth (NLVt) devices. Variations in energy, material, and dose for one or more of the implants discussed above may be applied depending on the specifications from the device design. Further, the implant conditions discussed above are presented solely for purposes of illustration and not by way of limitation. In the various embodiments, more or less implants can be used. Alternatively stated, other implants, other than those described above, can be utilized as well.
In some embodiments, instead of performing such implants, the additional dopants required for the NMOS devices can be added during the growth of the B-doped Si epi 204. For example, by varying the process conditions during growth of the B-doped Si epi 204, such as the ratio of dopant and silicon gases during a CVD process, the doping profile in the B-doped Si epi 204 can be tailored as needed. Accordingly, the well, screen, APT, and any other regions of the NMOS devices can be formed during formation of the B-doped Si epi 204.
Following the completion of the implants discussed above, additional patterned mask layers can be provided to apply additional implants to build out additional types of NMOS devices. For example, different sub-regions can be masked off to allow for preselected implants for the formation of NMOS standard Vth (NSVt) devices, NMOS SRAM devices in different sub-regions overlying the P-well. For each of these different device types, additional screen implants can be provided to change the Vth for each of these device types. NMOS analog devices can also be formed in the P-well by using appropriate implants. The doses and energies are selected to result in a targeted concentration of dopants and depth of doped region to provide a target Vth value for these devices. For instance, additional Boron may be implanted at an energy between about 2 keV to 10 keV at a dose of about 1×1012 to 1×1014 atoms/cm2. However, the various embodiments are not limited to this particular configuration, and the implant conditions may vary as needed to meet the Vth requirements for the device design. The implant conditions for the additional screen implants discussed are provided solely for illustrative purposes. Any suitable set of implants can be used in the various embodiments. Further, different devices can utilize common implants. Accordingly, the masking layers can be configured during the implantation process to allow a same implant to be used for multiple device types.
Once the implants for the NMOS regions are completed, all of the NMOS devices are covered over with a mask so that the doped regions for the PMOS regions can be formed. However, in the various embodiments, the existing blanket B-doped Si epi 204 must be considered when applying such PMOS implants. Specifically, the various embodiments require higher implant doses to provide sufficient counter-doping and provide sufficient N-type doping for the PMOS device. In particular embodiments, the implant doses will need to be high enough to counter the B doping in the B-doped Si epi 204. For example, if the in-situ doping B concentration is 5×1018/cm3, and the final desired n-type concentration is 8×1018/cm3, then the n-type implant dose would need to be tailored to generate a peak concentration of 1.3×1019/cm3 (8×1018/cm3+5×1018/cm3). In this example, the final n-type activation would achieve a compensated 8×1018/cm3 n-type region.
For example, as shown in
Then, optionally, and similar to the process described above with respect to
Referring back to
In the various embodiments, any type of anneal/activation process can be utilized. However, what is significant regarding the various embodiments is that since the Ge amorphization implant is no longer performed, the anneal process no longer requires the use of a regrowth or recrystallization anneal which requires a moderately high to high temperature over an extended period of time. Accordingly, the present disclosure contemplates that the anneal process following the formation of the NMOS and PMOS device regions can be skipped or performed via the use of a relatively low thermal budget anneal, effective to activate any implanted species and repair any local damage caused by the ion implantation.
The result of the foregoing process is that since the amount of B available to diffuse into the Si epi 214 is significantly reduced, the amount of migration into subsequently formed layers is also significantly reduced. Moreover, the higher-dose B implant processes (e.g., APT) are carried out at high energies, resulting in such high dose being located far from the interface between Si epi 214 and B-doped Si epi 204. Further, any additional migration due to the defects from incompletely recrystallized portions of the substrate and due to the thermal budget for recrystallization is no longer a concern.
Referring back to
The present disclosure contemplates that as part of the process of forming devices in active areas or regions of the semiconducting surface, some type of active area isolation is provided. Accordingly, following the formation of the second epitaxial layer 214 (step 108), isolation features can be formed to define different device regions (step 110). The result of this process is illustrated in
In the embodiments described above, the present disclosure contemplates that by reducing the amount of B introduced via implantation, the amount of B interstitials and silicon interstitial/vacancy pairs available to diffuse into the Si epi 214 are reduced. However, in some embodiments, additional NMOS implants may still lead to unwanted B diffusing into the Si epi 214. Moreover, some of the B incorporated into the B-doped Si epi 204 may still diffuse in to the Si epi 214 during anneal processes.
Accordingly, in particular embodiments, a barrier material-enhanced epitaxial layer is contemplated. More specifically, the first epitaxial layer deposited on the substrate can include a barrier material incorporated therein, such as carbon, selected in amounts aimed at suppressing migration of a dopant species. Two alternative exemplary processes are described below with respect to
The amount of C incorporated substitutionally into the silicon epitaxial layer can vary. In one particular embodiment, the substitutional C concentration can be selected such that it is less than or equal to 1% in silicon. For example, the concentration of substitutional C may typically be selected to be in the range of between about 1×1019 atoms/cm3 and about 1×1021 atoms/cm3. The B-doped C:Si epi 304 can be formed by introducing a C doping source in-situ into the B in situ-doped epitaxial process, and forming a blanket layer. In particular embodiments, a B-doped C:Si epi layer of less than 5 nm can be formed, however, the thickness can be as high as 20 nm or more in some embodiments. Such a layer can be deposited using a single epitaxial growth process. For example, in particular embodiments, a chemical vapor deposition (CVD) process can be used, where C is provided by way of a suitable precursor gas, such as methylsilane, and B is provided by way of a suitable precursor gas, such as diborane. In one particular embodiment, the epitaxial growth process can utilize processing temperatures of approximately 750C.
The result of the foregoing process is that not only are NMOS regions defined via an epitaxial deposition process rather than via implants, but subsequent B migration from the B-doped C:Si epi 304 is suppressed through the incorporation of C into the layer. As described above, the B doping can be selected such that no additional implants are needed for NMOS devices. However, as described above, the present disclosure also contemplates that some additional B implants may be needed for some types of devices. Thus additional masking and implants can be required, as illustrated in
Once the NMOS region 308 is formed, via formation of B-doped C:Si epi 304 alone or in combination with one or more implants, the PMOS region 312 can be formed, as shown in
As noted above, the presence of the blanket B-doped C:Si epi 304 will require different implant doses for the PMOS region than those previously described. Specifically, higher implant doses will be required in order to provide sufficient counter-doping to the in-situ B doping and provide sufficient N-type doping for the PMOS region. In particular embodiments, the implant doses will need to be high enough to counter the B doping in the B-doped Si epi 304. For example, if the in-situ doping B concentration is 5×1018/cm3, and the final desired n-type concentration is 8×1018 atoms/cm3, then the n-type implant dose would need to be tailored to generate a peak concentration of 1.3×1019/cm3 (=8×1018+5×1018). In this example, the final n-type activation would achieve a compensated 8×1018/cm3 n-type region.
After the implants are completed for the device regions 308 and 312, any remaining photoresist or other mask material (and any remaining sacrificial oxide) should be removed to expose the semiconducting surface including the implanted regions. The implanted dopants can then be activated via an anneal process, though without a recrystallization anneal, as previously described. Finally, the second epitaxial layer 314 and isolation features 316 can be formed, as discussed above with respect to
A further alternative process is, instead of incorporating the carbon into the in-situ doped B epitaxial process, to carry out the B in-situ doped epitaxial process first, and then follow with a C in-situ doped epitaxial process. An extra layer of epitaxial material is therefore contemplated, the in-situ B doped epitaxial layer, the in-situ C doped epitaxial layer and the substantially undoped epitaxial layer formed preferably after the NMOS and PMOS device regions have been doped. If a C in-situ doped epitaxial layer is used, then the C concentration is selected so that the C is effective to inhibit migration of doped species in particular, boron, while keeping the thickness of the C in-situ doped epitaxial layer to a minimum. The thickness of the C in-situ doped epitaxial layer can be as little as 5 nm or less, but may need to be thicker to ensure the effectiveness of the layer to inhibit diffusion. Following the deposition of the C in-situ doped epitaxial layer, the substantially undoped epitaxial silicon layer can be formed. Advantageously, by the process described in this embodiment, the C-doped region is restricted to the bottom portion of the transistor channel. The substantially undoped epitaxial silicon layer can remain such and be devoid of carbon constituents. In this example, the final thickness of the undoped epitaxial silicon layer can be adjusted to take into account the thickness of the C doped diffusion inhibiting layer. For example, if the C doped layer were 5 nm, and the final desired thickness of the channel were 25 nm, then 20 nm of undoped epitaxial silicon can be grown over the 5 nm carbon doped layer giving rise to a 25 nm channel region free from intentional n-type or p-type dopants. The described process incorporating a separate C in-situ doped epitaxial layer can be used in combination with a C-doped in situ-B epitaxial layer underneath as well.
The various embodiments described above contemplate that the B and C incorporated in-situ will result in a profile of B and C along a vertical direction normal to the substrate 302 in which the amount of C and B is approximately the same or equal throughout the thickness of the B-doped C:Si epi 304. As used herein, the terms “approximately the same” or “approximately equal” refer to the measurement being compared as having a relative difference of 10% or less. In some embodiments, the amount of C, B, or both can vary along the thickness of the B-doped C:Si epi 304. That is, the amount of C or B can vary along a vertical direction normal to the substrate 302 such that the amount of C, B, or both is not approximately the same along this vertical direction. For example, as shown in
The present disclosure also contemplates that in some cases, it may be undesirable to include a C-comprising portion for certain types of devices. For instance, whereas C incorporation is important to inhibit B migration on the NMOS side, the presence of C anywhere in the PMOS region may be problematic. If it is desired to exclude C in the PMOS regions, then, after forming the blanket B-doped Si epitaxial layer and the subsequent blanket C-doped Si epitaxial layer, then the NMOS regions can be masked leaving the PMOS regions exposed, whereupon a selective etch process can be used to remove the in-situ C-doped layer from the PMOS region. This etching can be performed as follows. First, a patterned masking layer can be formed to expose the regions of C-comprising portions to be etched. In some embodiments, the masking layer can consisting of a single layer of photoresist. In other embodiments, the masking layer can consist of a hard mask, separately or in combination with the photoresist layer. Such a hard mask can be a layer of silicon oxide, silicon nitride, or any other material which will be resistant to the removal process to be used for the epitaxial layer.
Once the pattern is formed, a selective removal process is utilized to reduce the thickness of the C-comprising portions. As used herein, the term “selective removal process” refers to any type of removal process that preferentially removes one type of material over another type of material. This can include, but is not limited to, any type of wet or dry, chemical, physical, or plasma-based etch processes for removing materials. In the case of C:Si epi, the selective removal process would be configured to preferentially remove C:Si epi over photoresist material and other masking materials. As noted above, the specific process for the selective removal process can vary depending on the amount of material to be removed and the amount of epitaxial layer thickness variability permitted. After the selective removal process is performed, the photoresist or other masking layer can be removed to expose the surfaces of the semiconducting surface.
This etching process can be performed at various points in the method of
While various embodiments have been described above, it should be understood that they have been presented by way of example only, and not limitation. Numerous changes to the disclosed embodiments can be made in accordance with the disclosure herein without departing from the spirit or scope of the invention. Thus, the breadth and scope of the present invention should not be limited by any of the above described embodiments. Rather, the scope of the invention should be defined in accordance with the following claims and their equivalents.
Although the embodiments have been illustrated and described with respect to one or more implementations, equivalent alterations and modifications will occur to others skilled in the art upon the reading and understanding of this specification and the annexed drawings. In addition, while a particular feature may have been disclosed with respect to only one of several implementations, such feature may be combined with one or more other features of the other implementations as may be desired and advantageous for any given or particular application.
The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. Furthermore, to the extent that the terms “including”, “includes”, “having”, “has”, “with”, or variants thereof are used in either the detailed description and/or the claims, such terms are intended to be inclusive in a manner similar to the term “comprising.”
Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.
Number | Name | Date | Kind |
---|---|---|---|
3958266 | Athanas | May 1976 | A |
4000504 | Berger | Dec 1976 | A |
4021835 | Etoh et al. | May 1977 | A |
4242691 | Kotani et al. | Dec 1980 | A |
4276095 | Beilstein, Jr. et al. | Jun 1981 | A |
4315781 | Henderson | Feb 1982 | A |
4518926 | Swanson | May 1985 | A |
4559091 | Allen et al. | Dec 1985 | A |
4578128 | Mundt et al. | Mar 1986 | A |
4617066 | Vasudev | Oct 1986 | A |
4662061 | Malhi | May 1987 | A |
4761384 | Neppl et al. | Aug 1988 | A |
4780748 | Cunningham et al. | Oct 1988 | A |
4819043 | Yazawa et al. | Apr 1989 | A |
4885477 | Bird et al. | Dec 1989 | A |
4908681 | Nishida et al. | Mar 1990 | A |
4945254 | Robbins | Jul 1990 | A |
4956311 | Liou et al. | Sep 1990 | A |
5034337 | Mosher et al. | Jul 1991 | A |
5144378 | Hikosaka | Sep 1992 | A |
5156989 | Williams et al. | Oct 1992 | A |
5156990 | Mitchell | Oct 1992 | A |
5166765 | Lee et al. | Nov 1992 | A |
5208473 | Komori et al. | May 1993 | A |
5294821 | Iwamatsu | Mar 1994 | A |
5298763 | Shen et al. | Mar 1994 | A |
5369288 | Usuki | Nov 1994 | A |
5373186 | Schubert et al. | Dec 1994 | A |
5384476 | Nishizawa et al. | Jan 1995 | A |
5426328 | Yilmaz et al. | Jun 1995 | A |
5444008 | Han et al. | Aug 1995 | A |
5552332 | Tseng et al. | Sep 1996 | A |
5559368 | Hu et al. | Sep 1996 | A |
5608253 | Liu et al. | Mar 1997 | A |
5622880 | Burr et al. | Apr 1997 | A |
5624863 | Helm et al. | Apr 1997 | A |
5625568 | Edwards et al. | Apr 1997 | A |
5641980 | Yamaguchi et al. | Jun 1997 | A |
5663583 | Matloubian et al. | Sep 1997 | A |
5712501 | Davies et al. | Jan 1998 | A |
5719422 | Burr et al. | Feb 1998 | A |
5726488 | Watanabe et al. | Mar 1998 | A |
5726562 | Mizuno | Mar 1998 | A |
5731626 | Eaglesham et al. | Mar 1998 | A |
5736419 | Naem | Apr 1998 | A |
5753555 | Hada | May 1998 | A |
5754826 | Gamal et al. | May 1998 | A |
5756365 | Kakumu | May 1998 | A |
5763921 | Okumura et al. | Jun 1998 | A |
5780899 | Hu et al. | Jul 1998 | A |
5847419 | Imai et al. | Dec 1998 | A |
5856003 | Chiu | Jan 1999 | A |
5861334 | Rho | Jan 1999 | A |
5877049 | Liu et al. | Mar 1999 | A |
5885876 | Dennen | Mar 1999 | A |
5889315 | Farrenkopf et al. | Mar 1999 | A |
5895954 | Yasumura et al. | Apr 1999 | A |
5899714 | Farrenkopf et al. | May 1999 | A |
5918129 | Fulford, Jr. et al. | Jun 1999 | A |
5923067 | Voldman | Jul 1999 | A |
5923987 | Burr | Jul 1999 | A |
5936868 | Hall | Aug 1999 | A |
5946214 | Heavlin et al. | Aug 1999 | A |
5985705 | Seliskar | Nov 1999 | A |
5989963 | Luning et al. | Nov 1999 | A |
6001695 | Wu | Dec 1999 | A |
6020227 | Bulucea | Feb 2000 | A |
6043139 | Eaglesham et al. | Mar 2000 | A |
6060345 | Hause et al. | May 2000 | A |
6060364 | Maszara et al. | May 2000 | A |
6066533 | Yu | May 2000 | A |
6072217 | Burr | Jun 2000 | A |
6087210 | Sohn | Jul 2000 | A |
6087691 | Hamamoto | Jul 2000 | A |
6088518 | Hsu | Jul 2000 | A |
6091286 | Blauschild | Jul 2000 | A |
6096611 | Wu | Aug 2000 | A |
6103562 | Son et al. | Aug 2000 | A |
6121153 | Kikkawa | Sep 2000 | A |
6147383 | Kuroda | Nov 2000 | A |
6153920 | Gossmann et al. | Nov 2000 | A |
6157073 | Lehongres | Dec 2000 | A |
6175582 | Naito et al. | Jan 2001 | B1 |
6184112 | Maszara et al. | Feb 2001 | B1 |
6190979 | Radens et al. | Feb 2001 | B1 |
6194259 | Nayak et al. | Feb 2001 | B1 |
6198157 | Ishida et al. | Mar 2001 | B1 |
6218892 | Soumyanath et al. | Apr 2001 | B1 |
6218895 | De et al. | Apr 2001 | B1 |
6221724 | Yu et al. | Apr 2001 | B1 |
6229188 | Aoki et al. | May 2001 | B1 |
6232164 | Tsai et al. | May 2001 | B1 |
6235597 | Miles | May 2001 | B1 |
6245618 | An et al. | Jun 2001 | B1 |
6268640 | Park et al. | Jul 2001 | B1 |
6271070 | Kotani et al. | Aug 2001 | B2 |
6271551 | Schmitz et al. | Aug 2001 | B1 |
6288429 | Iwata et al. | Sep 2001 | B1 |
6297132 | Zhang et al. | Oct 2001 | B1 |
6300177 | Sundaresan et al. | Oct 2001 | B1 |
6300209 | Oh | Oct 2001 | B1 |
6313489 | Letavic et al. | Nov 2001 | B1 |
6319799 | Ouyang et al. | Nov 2001 | B1 |
6320222 | Forbes et al. | Nov 2001 | B1 |
6323525 | Noguchi et al. | Nov 2001 | B1 |
6326666 | Bernstein et al. | Dec 2001 | B1 |
6335233 | Cho et al. | Jan 2002 | B1 |
6358806 | Puchner | Mar 2002 | B1 |
6380019 | Yu et al. | Apr 2002 | B1 |
6391752 | Colinge et al. | May 2002 | B1 |
6426260 | Hshieh | Jul 2002 | B1 |
6426279 | Huster et al. | Jul 2002 | B1 |
6432754 | Assaderaghi et al. | Aug 2002 | B1 |
6444550 | Hao et al. | Sep 2002 | B1 |
6444551 | Ku et al. | Sep 2002 | B1 |
6449749 | Stine | Sep 2002 | B1 |
6461920 | Shirahata | Oct 2002 | B1 |
6461928 | Rodder | Oct 2002 | B2 |
6472278 | Marshall et al. | Oct 2002 | B1 |
6482714 | Hieda et al. | Nov 2002 | B1 |
6489224 | Burr | Dec 2002 | B1 |
6492232 | Tang et al. | Dec 2002 | B1 |
6500739 | Wang et al. | Dec 2002 | B1 |
6503801 | Rouse et al. | Jan 2003 | B1 |
6503805 | Wang et al. | Jan 2003 | B2 |
6506640 | Ishida et al. | Jan 2003 | B1 |
6518623 | Oda et al. | Feb 2003 | B1 |
6521470 | Lin et al. | Feb 2003 | B1 |
6534373 | Yu | Mar 2003 | B1 |
6541328 | Whang et al. | Apr 2003 | B2 |
6541829 | Nishinohara et al. | Apr 2003 | B2 |
6548842 | Bulucea et al. | Apr 2003 | B1 |
6551885 | Yu | Apr 2003 | B1 |
6552377 | Yu | Apr 2003 | B1 |
6573129 | Hoke et al. | Jun 2003 | B2 |
6576535 | Drobny et al. | Jun 2003 | B2 |
6600200 | Lustig et al. | Jul 2003 | B1 |
6620671 | Wang et al. | Sep 2003 | B1 |
6624488 | Kim | Sep 2003 | B1 |
6627473 | Oikawa et al. | Sep 2003 | B1 |
6630710 | Augusto | Oct 2003 | B1 |
6660605 | Liu | Dec 2003 | B1 |
6662350 | Fried et al. | Dec 2003 | B2 |
6667200 | Sohn et al. | Dec 2003 | B2 |
6670260 | Yu et al. | Dec 2003 | B1 |
6693333 | Yu | Feb 2004 | B1 |
6730568 | Sohn | May 2004 | B2 |
6737724 | Hieda et al. | May 2004 | B2 |
6743291 | Ang et al. | Jun 2004 | B2 |
6743684 | Liu | Jun 2004 | B2 |
6751519 | Satya et al. | Jun 2004 | B1 |
6753230 | Sohn et al. | Jun 2004 | B2 |
6760900 | Rategh et al. | Jul 2004 | B2 |
6770944 | Nishinohara et al. | Aug 2004 | B2 |
6787424 | Yu | Sep 2004 | B1 |
6797553 | Adkisson et al. | Sep 2004 | B2 |
6797602 | Kluth et al. | Sep 2004 | B1 |
6797994 | Hoke et al. | Sep 2004 | B1 |
6808004 | Kamm et al. | Oct 2004 | B2 |
6808994 | Wang | Oct 2004 | B1 |
6813750 | Usami et al. | Nov 2004 | B2 |
6821825 | Todd et al. | Nov 2004 | B2 |
6821852 | Rhodes | Nov 2004 | B2 |
6822297 | Nandakumar et al. | Nov 2004 | B2 |
6831292 | Currie et al. | Dec 2004 | B2 |
6835639 | Rotondaro et al. | Dec 2004 | B2 |
6852602 | Kanzawa et al. | Feb 2005 | B2 |
6852603 | Chakravarthi et al. | Feb 2005 | B2 |
6881641 | Wieczorek et al. | Apr 2005 | B2 |
6881987 | Sohn | Apr 2005 | B2 |
6891439 | Jachne et al. | May 2005 | B2 |
6893947 | Martinez et al. | May 2005 | B2 |
6900519 | Cantell et al. | May 2005 | B2 |
6901564 | Stine et al. | May 2005 | B2 |
6916698 | Mocuta et al. | Jul 2005 | B2 |
6917237 | Tschanz et al. | Jul 2005 | B1 |
6927463 | Iwata et al. | Aug 2005 | B2 |
6928128 | Sidiropoulos | Aug 2005 | B1 |
6930007 | Bu et al. | Aug 2005 | B2 |
6930360 | Yamauchi et al. | Aug 2005 | B2 |
6957163 | Ando | Oct 2005 | B2 |
6963090 | Passlack et al. | Nov 2005 | B2 |
6972223 | Weimer et al. | Dec 2005 | B2 |
6995397 | Yamashita et al. | Feb 2006 | B2 |
7002214 | Boyd et al. | Feb 2006 | B1 |
7008836 | Algotsson et al. | Mar 2006 | B2 |
7013359 | Li | Mar 2006 | B1 |
7015546 | Herr et al. | Mar 2006 | B2 |
7015741 | Tschanz et al. | Mar 2006 | B2 |
7022559 | Barnak et al. | Apr 2006 | B2 |
7036098 | Eleyan et al. | Apr 2006 | B2 |
7038258 | Liu et al. | May 2006 | B2 |
7039881 | Regan | May 2006 | B2 |
7045456 | Murto et al. | May 2006 | B2 |
7057216 | Ouyang et al. | Jun 2006 | B2 |
7061058 | Chakravarthi et al. | Jun 2006 | B2 |
7064039 | Liu | Jun 2006 | B2 |
7064399 | Babcock et al. | Jun 2006 | B2 |
7071103 | Chan et al. | Jul 2006 | B2 |
7078325 | Curello et al. | Jul 2006 | B2 |
7078776 | Nishinohara et al. | Jul 2006 | B2 |
7089513 | Bard et al. | Aug 2006 | B2 |
7089515 | Hanafi et al. | Aug 2006 | B2 |
7091093 | Noda et al. | Aug 2006 | B1 |
7105399 | Dakshina-Murthy et al. | Sep 2006 | B1 |
7109099 | Tan et al. | Sep 2006 | B2 |
7119381 | Passlack | Oct 2006 | B2 |
7122411 | Mouli | Oct 2006 | B2 |
7127687 | Signore | Oct 2006 | B1 |
7132323 | Haensch et al. | Nov 2006 | B2 |
7169675 | Tan et al. | Jan 2007 | B2 |
7170120 | Datta et al. | Jan 2007 | B2 |
7176137 | Perng et al. | Feb 2007 | B2 |
7186598 | Yamauchi et al. | Mar 2007 | B2 |
7189627 | Wu et al. | Mar 2007 | B2 |
7199430 | Babcock et al. | Apr 2007 | B2 |
7202517 | Dixit et al. | Apr 2007 | B2 |
7208354 | Bauer | Apr 2007 | B2 |
7211871 | Cho | May 2007 | B2 |
7221021 | Wu et al. | May 2007 | B2 |
7223646 | Miyashita et al. | May 2007 | B2 |
7226833 | White et al. | Jun 2007 | B2 |
7226843 | Weber et al. | Jun 2007 | B2 |
7230680 | Fujisawa et al. | Jun 2007 | B2 |
7235822 | Li | Jun 2007 | B2 |
7256639 | Koniaris et al. | Aug 2007 | B1 |
7259428 | Inaba | Aug 2007 | B2 |
7260562 | Czajkowski et al. | Aug 2007 | B2 |
7294877 | Rueckes et al. | Nov 2007 | B2 |
7297994 | Wieczorek et al. | Nov 2007 | B2 |
7301208 | Handa et al. | Nov 2007 | B2 |
7304350 | Misaki | Dec 2007 | B2 |
7307471 | Gammie et al. | Dec 2007 | B2 |
7312500 | Miyashita et al. | Dec 2007 | B2 |
7323754 | Ema et al. | Jan 2008 | B2 |
7332439 | Lindert et al. | Feb 2008 | B2 |
7339215 | Chidambaram | Mar 2008 | B2 |
7348629 | Chu et al. | Mar 2008 | B2 |
7354833 | Liaw | Apr 2008 | B2 |
7380225 | Joshi et al. | May 2008 | B2 |
7398497 | Sato et al. | Jul 2008 | B2 |
7402207 | Besser et al. | Jul 2008 | B1 |
7402872 | Murthy et al. | Jul 2008 | B2 |
7416605 | Zollner et al. | Aug 2008 | B2 |
7427788 | Li et al. | Sep 2008 | B2 |
7442971 | Wirbeleit et al. | Oct 2008 | B2 |
7449733 | Inaba et al. | Nov 2008 | B2 |
7462908 | Bol et al. | Dec 2008 | B2 |
7469164 | Du-Nour | Dec 2008 | B2 |
7470593 | Rouh et al. | Dec 2008 | B2 |
7485536 | Jin et al. | Feb 2009 | B2 |
7487474 | Ciplickas et al. | Feb 2009 | B2 |
7491988 | Tolchinsky et al. | Feb 2009 | B2 |
7494861 | Chu et al. | Feb 2009 | B2 |
7496862 | Chang et al. | Feb 2009 | B2 |
7496867 | Turner et al. | Feb 2009 | B2 |
7498637 | Yamaoka et al. | Mar 2009 | B2 |
7501324 | Babcock et al. | Mar 2009 | B2 |
7503020 | Allen et al. | Mar 2009 | B2 |
7507999 | Kusumoto et al. | Mar 2009 | B2 |
7514766 | Yoshida | Apr 2009 | B2 |
7521323 | Surdeanu et al. | Apr 2009 | B2 |
7524740 | Liu et al. | Apr 2009 | B1 |
7531393 | Doyle et al. | May 2009 | B2 |
7531836 | Liu et al. | May 2009 | B2 |
7538364 | Twynam | May 2009 | B2 |
7538412 | Schulze et al. | May 2009 | B2 |
7553717 | Chakravarthi et al. | Jun 2009 | B2 |
7562233 | Sheng et al. | Jul 2009 | B1 |
7564105 | Chi et al. | Jul 2009 | B2 |
7566600 | Mouli | Jul 2009 | B2 |
7569456 | Ko et al. | Aug 2009 | B2 |
7586322 | Xu et al. | Sep 2009 | B1 |
7592241 | Takao | Sep 2009 | B2 |
7595243 | Bulucea et al. | Sep 2009 | B1 |
7598142 | Ranade et al. | Oct 2009 | B2 |
7605041 | Ema et al. | Oct 2009 | B2 |
7605060 | Meunier-Beillard et al. | Oct 2009 | B2 |
7605429 | Bernstein et al. | Oct 2009 | B2 |
7608496 | Chu | Oct 2009 | B2 |
7615802 | Elpelt et al. | Nov 2009 | B2 |
7622341 | Chudzik et al. | Nov 2009 | B2 |
7638380 | Pearce | Dec 2009 | B2 |
7642140 | Bae et al. | Jan 2010 | B2 |
7644377 | Saxe et al. | Jan 2010 | B1 |
7645665 | Kubo et al. | Jan 2010 | B2 |
7651920 | Siprak | Jan 2010 | B2 |
7655523 | Babcock et al. | Feb 2010 | B2 |
7673273 | Madurawe et al. | Mar 2010 | B2 |
7675126 | Cho | Mar 2010 | B2 |
7675317 | Perisetty | Mar 2010 | B2 |
7678631 | Murthy et al. | Mar 2010 | B2 |
7678638 | Chu et al. | Mar 2010 | B2 |
7681628 | Joshi et al. | Mar 2010 | B2 |
7682887 | Dokumaci et al. | Mar 2010 | B2 |
7683442 | Burr et al. | Mar 2010 | B1 |
7696000 | Liu et al. | Apr 2010 | B2 |
7704822 | Jeong | Apr 2010 | B2 |
7704844 | Zhu et al. | Apr 2010 | B2 |
7709828 | Braithwaite et al. | May 2010 | B2 |
7723750 | Zhu et al. | May 2010 | B2 |
7737472 | Kondo et al. | Jun 2010 | B2 |
7741138 | Cho | Jun 2010 | B2 |
7741200 | Cho et al. | Jun 2010 | B2 |
7745270 | Shah et al. | Jun 2010 | B2 |
7750374 | Capasso et al. | Jul 2010 | B2 |
7750381 | Hokazono et al. | Jul 2010 | B2 |
7750405 | Nowak | Jul 2010 | B2 |
7750682 | Bernstein et al. | Jul 2010 | B2 |
7755144 | Li et al. | Jul 2010 | B2 |
7755146 | Helm et al. | Jul 2010 | B2 |
7759206 | Luo et al. | Jul 2010 | B2 |
7759714 | Itoh et al. | Jul 2010 | B2 |
7761820 | Berger et al. | Jul 2010 | B2 |
7795677 | Bangsaruntip et al. | Sep 2010 | B2 |
7808045 | Kawahara et al. | Oct 2010 | B2 |
7808410 | Kim et al. | Oct 2010 | B2 |
7811873 | Mochizuki | Oct 2010 | B2 |
7811881 | Cheng et al. | Oct 2010 | B2 |
7818702 | Mandelman et al. | Oct 2010 | B2 |
7821066 | Lebby et al. | Oct 2010 | B2 |
7829402 | Matocha et al. | Nov 2010 | B2 |
7831873 | Trimberger et al. | Nov 2010 | B1 |
7846822 | Seebauer et al. | Dec 2010 | B2 |
7855118 | Hoentschel et al. | Dec 2010 | B2 |
7859013 | Chen et al. | Dec 2010 | B2 |
7863163 | Bauer | Jan 2011 | B2 |
7867835 | Lee et al. | Jan 2011 | B2 |
7883977 | Babcock et al. | Feb 2011 | B2 |
7888205 | Herner et al. | Feb 2011 | B2 |
7888747 | Hokazono | Feb 2011 | B2 |
7895546 | Lahner et al. | Feb 2011 | B2 |
7897495 | Ye et al. | Mar 2011 | B2 |
7906413 | Cardone et al. | Mar 2011 | B2 |
7906813 | Kato | Mar 2011 | B2 |
7910419 | Fenouillet-Beranger et al. | Mar 2011 | B2 |
7919791 | Flynn et al. | Apr 2011 | B2 |
7926018 | Moroz et al. | Apr 2011 | B2 |
7935984 | Nakano | May 2011 | B2 |
7941776 | Majumder et al. | May 2011 | B2 |
7945800 | Gomm et al. | May 2011 | B2 |
7948008 | Liu et al. | May 2011 | B2 |
7952147 | Ueno et al. | May 2011 | B2 |
7960232 | King et al. | Jun 2011 | B2 |
7960238 | Kohli et al. | Jun 2011 | B2 |
7968400 | Cai | Jun 2011 | B2 |
7968411 | Williford | Jun 2011 | B2 |
7968440 | Seebauer | Jun 2011 | B2 |
7968459 | Bedell et al. | Jun 2011 | B2 |
7989900 | Haensch et al. | Aug 2011 | B2 |
7994573 | Pan | Aug 2011 | B2 |
8004024 | Furukawa et al. | Aug 2011 | B2 |
8012827 | Yu et al. | Sep 2011 | B2 |
8029620 | Kim et al. | Oct 2011 | B2 |
8039332 | Bernard et al. | Oct 2011 | B2 |
8046598 | Lee | Oct 2011 | B2 |
8048791 | Hargrove et al. | Nov 2011 | B2 |
8048810 | Tsai et al. | Nov 2011 | B2 |
8051340 | Cranford, Jr. et al. | Nov 2011 | B2 |
8053340 | Colombeau et al. | Nov 2011 | B2 |
8063466 | Kurita | Nov 2011 | B2 |
8067279 | Sadra et al. | Nov 2011 | B2 |
8067280 | Wang et al. | Nov 2011 | B2 |
8067302 | Li | Nov 2011 | B2 |
8076719 | Zeng et al. | Dec 2011 | B2 |
8097529 | Krull et al. | Jan 2012 | B2 |
8103983 | Agarwal et al. | Jan 2012 | B2 |
8105891 | Yeh et al. | Jan 2012 | B2 |
8106424 | Schruefer | Jan 2012 | B2 |
8106481 | Rao | Jan 2012 | B2 |
8110487 | Griebenow et al. | Feb 2012 | B2 |
8114761 | Mandrekar et al. | Feb 2012 | B2 |
8119482 | Bhalla et al. | Feb 2012 | B2 |
8120069 | Hynecek | Feb 2012 | B2 |
8129246 | Babcock et al. | Mar 2012 | B2 |
8129797 | Chen et al. | Mar 2012 | B2 |
8134159 | Hokazono | Mar 2012 | B2 |
8143120 | Kerr et al. | Mar 2012 | B2 |
8143124 | Challa et al. | Mar 2012 | B2 |
8143678 | Kim et al. | Mar 2012 | B2 |
8148774 | Mori et al. | Apr 2012 | B2 |
8163619 | Yang et al. | Apr 2012 | B2 |
8169002 | Chang et al. | May 2012 | B2 |
8170857 | Joshi et al. | May 2012 | B2 |
8173499 | Chung et al. | May 2012 | B2 |
8173502 | Yan et al. | May 2012 | B2 |
8176461 | Trimberger | May 2012 | B1 |
8178430 | Kim et al. | May 2012 | B2 |
8179530 | Levy et al. | May 2012 | B2 |
8183096 | Wirbeleit | May 2012 | B2 |
8183107 | Mathur et al. | May 2012 | B2 |
8185865 | Gupta et al. | May 2012 | B2 |
8187959 | Pawlak et al. | May 2012 | B2 |
8188542 | Yoo et al. | May 2012 | B2 |
8196545 | Kurosawa | Jun 2012 | B2 |
8201122 | Dewey, III et al. | Jun 2012 | B2 |
8214190 | Joshi et al. | Jul 2012 | B2 |
8217423 | Liu et al. | Jul 2012 | B2 |
8225255 | Ouyang et al. | Jul 2012 | B2 |
8227307 | Chen et al. | Jul 2012 | B2 |
8236661 | Dennard et al. | Aug 2012 | B2 |
8239803 | Kobayashi | Aug 2012 | B2 |
8247300 | Babcock et al. | Aug 2012 | B2 |
8255843 | Chen et al. | Aug 2012 | B2 |
8258026 | Bulucea | Sep 2012 | B2 |
8266567 | El Yahyaoui et al. | Sep 2012 | B2 |
8273617 | Thompson et al. | Sep 2012 | B2 |
8286180 | Foo | Oct 2012 | B2 |
8288798 | Passlack | Oct 2012 | B2 |
8298901 | Foote et al. | Oct 2012 | B1 |
8299562 | Li et al. | Oct 2012 | B2 |
8324059 | Guo et al. | Dec 2012 | B2 |
8569156 | Scudder et al. | Oct 2013 | B1 |
20010014495 | Yu | Aug 2001 | A1 |
20020033511 | Babcock et al. | Mar 2002 | A1 |
20020042184 | Nandakumar et al. | Apr 2002 | A1 |
20020151153 | Drobny et al. | Oct 2002 | A1 |
20030006415 | Yokogawa et al. | Jan 2003 | A1 |
20030047763 | Hieda et al. | Mar 2003 | A1 |
20030122203 | Nishinohara et al. | Jul 2003 | A1 |
20030173626 | Burr | Sep 2003 | A1 |
20030183856 | Wieczorek et al. | Oct 2003 | A1 |
20030215992 | Sohn et al. | Nov 2003 | A1 |
20040051104 | Yamashita et al. | Mar 2004 | A1 |
20040053457 | Sohn | Mar 2004 | A1 |
20040075118 | Heinemann et al. | Apr 2004 | A1 |
20040075143 | Bae et al. | Apr 2004 | A1 |
20040084731 | Matsuda et al. | May 2004 | A1 |
20040087090 | Grudowski et al. | May 2004 | A1 |
20040126947 | Sohn | Jul 2004 | A1 |
20040175893 | Vatus et al. | Sep 2004 | A1 |
20040180488 | Lee | Sep 2004 | A1 |
20050056877 | Rueckes et al. | Mar 2005 | A1 |
20050106800 | Haensch et al. | May 2005 | A1 |
20050106824 | Alberto et al. | May 2005 | A1 |
20050116282 | Pattanayak et al. | Jun 2005 | A1 |
20050250289 | Babcock et al. | Nov 2005 | A1 |
20050280075 | Ema et al. | Dec 2005 | A1 |
20060017100 | Bol et al. | Jan 2006 | A1 |
20060022270 | Boyd et al. | Feb 2006 | A1 |
20060024876 | Chidambaram | Feb 2006 | A1 |
20060049464 | Rao | Mar 2006 | A1 |
20060068555 | Zhu et al. | Mar 2006 | A1 |
20060068586 | Pain | Mar 2006 | A1 |
20060071278 | Takao | Apr 2006 | A1 |
20060091481 | Li et al. | May 2006 | A1 |
20060154428 | Dokumaci | Jul 2006 | A1 |
20060157794 | Doyle et al. | Jul 2006 | A1 |
20060197158 | Babcock et al. | Sep 2006 | A1 |
20060203581 | Joshi et al. | Sep 2006 | A1 |
20060220114 | Miyashita et al. | Oct 2006 | A1 |
20060223248 | Venugopal et al. | Oct 2006 | A1 |
20070040222 | Van Camp et al. | Feb 2007 | A1 |
20070117326 | Tan et al. | May 2007 | A1 |
20070158790 | Rao | Jul 2007 | A1 |
20070212861 | Chidambarrao et al. | Sep 2007 | A1 |
20070238253 | Tucker | Oct 2007 | A1 |
20080067589 | Ito et al. | Mar 2008 | A1 |
20080108208 | Arevalo et al. | May 2008 | A1 |
20080138953 | Challa et al. | Jun 2008 | A1 |
20080169493 | Lee et al. | Jul 2008 | A1 |
20080169516 | Chung | Jul 2008 | A1 |
20080194069 | Surdeanu et al. | Aug 2008 | A1 |
20080197439 | Goerlach et al. | Aug 2008 | A1 |
20080199999 | Weijtmans et al. | Aug 2008 | A1 |
20080227250 | Ranade et al. | Sep 2008 | A1 |
20080237661 | Ranade et al. | Oct 2008 | A1 |
20080258198 | Bojarczuk et al. | Oct 2008 | A1 |
20080272409 | Sonkusale et al. | Nov 2008 | A1 |
20090003105 | Itoh et al. | Jan 2009 | A1 |
20090057746 | Sugll et al. | Mar 2009 | A1 |
20090057762 | Bangsaruntip et al. | Mar 2009 | A1 |
20090079008 | Nandakumar et al. | Mar 2009 | A1 |
20090081858 | Qin et al. | Mar 2009 | A1 |
20090108350 | Cai et al. | Apr 2009 | A1 |
20090121298 | Furukawa et al. | May 2009 | A1 |
20090134468 | Tsuchiya et al. | May 2009 | A1 |
20090179280 | Kohli et al. | Jul 2009 | A1 |
20090224319 | Kohli | Sep 2009 | A1 |
20090278209 | Noda | Nov 2009 | A1 |
20090286367 | Krull et al. | Nov 2009 | A1 |
20090302388 | Cai et al. | Dec 2009 | A1 |
20090309140 | Khamankar et al. | Dec 2009 | A1 |
20090311837 | Kapoor | Dec 2009 | A1 |
20090321849 | Miyamura et al. | Dec 2009 | A1 |
20100012988 | Yang et al. | Jan 2010 | A1 |
20100038724 | Anderson et al. | Feb 2010 | A1 |
20100078729 | Fukutome et al. | Apr 2010 | A1 |
20100100856 | Mittal | Apr 2010 | A1 |
20100133624 | Nandakumar et al. | Jun 2010 | A1 |
20100148153 | Hudait et al. | Jun 2010 | A1 |
20100149854 | Vora | Jun 2010 | A1 |
20100187641 | Zhu et al. | Jul 2010 | A1 |
20100207182 | Paschal | Aug 2010 | A1 |
20100270600 | Inukai et al. | Oct 2010 | A1 |
20100276761 | Tung et al. | Nov 2010 | A1 |
20110059588 | Kang | Mar 2011 | A1 |
20110073961 | Dennard et al. | Mar 2011 | A1 |
20110074498 | Thompson et al. | Mar 2011 | A1 |
20110079860 | Verhulst | Apr 2011 | A1 |
20110079861 | Shifren et al. | Apr 2011 | A1 |
20110095811 | Chi et al. | Apr 2011 | A1 |
20110147828 | Murthy et al. | Jun 2011 | A1 |
20110169082 | Zhu et al. | Jul 2011 | A1 |
20110175140 | Taylor et al. | Jul 2011 | A1 |
20110175170 | Wang et al. | Jul 2011 | A1 |
20110180880 | Chudzik et al. | Jul 2011 | A1 |
20110193164 | Zhu | Aug 2011 | A1 |
20110212590 | Wu et al. | Sep 2011 | A1 |
20110230039 | Mowry et al. | Sep 2011 | A1 |
20110242921 | Tran et al. | Oct 2011 | A1 |
20110248352 | Shifren | Oct 2011 | A1 |
20110294278 | Eguchi et al. | Dec 2011 | A1 |
20110309447 | Arghavani et al. | Dec 2011 | A1 |
20120021594 | Gurtej et al. | Jan 2012 | A1 |
20120034745 | Colombeau et al. | Feb 2012 | A1 |
20120056275 | Cai et al. | Mar 2012 | A1 |
20120065920 | Nagumo et al. | Mar 2012 | A1 |
20120108050 | Chen et al. | May 2012 | A1 |
20120132998 | Kwon et al. | May 2012 | A1 |
20120138953 | Cai et al. | Jun 2012 | A1 |
20120146155 | Hoentschel et al. | Jun 2012 | A1 |
20120161210 | Heinrich et al. | Jun 2012 | A1 |
20120167025 | Gillespie et al. | Jun 2012 | A1 |
20120187491 | Zhu et al. | Jul 2012 | A1 |
20120190177 | Kim et al. | Jul 2012 | A1 |
20120223363 | Kronholz et al. | Sep 2012 | A1 |
Number | Date | Country |
---|---|---|
0274278 | Jul 1988 | EP |
0312237 | Apr 1989 | EP |
0531621 | Mar 1993 | EP |
0683515 | Nov 1995 | EP |
0889502 | Jan 1999 | EP |
1450394 | Aug 2004 | EP |
59193066 | Nov 1984 | JP |
4186774 | Jul 1992 | JP |
8153873 | Jun 1996 | JP |
8288508 | Nov 1996 | JP |
2004087671 | Mar 2004 | JP |
794094 | Jan 2008 | KR |
WO2005093831 | Oct 2005 | WO |
WO2011062788 | May 2011 | WO |
Entry |
---|
Abiko, H et al., “A Channel Engineering Combined with Channel Epitaxy Optimization and TED Suppression for 0.15μm n-n Gate CMOS Technology”, 1995 Symposium on VLSI Technology Digest of Technical Papers, pp. 23-24, 1995. |
Chau, R et al., “A 50nm Depleted-Substrate CMOS Transistor (DST)”, Electron Device Meeting 2001, IEDM Technical Digest, IEEE International, pp. 29.1.1-29.1.4, 2001. |
Ducroquet, F et al. “Fully Depleted Silicon-On-Insulator nMOSFETs with Tensile Strained High Carbon Content Si1-yCy Channel”, ECS 210th Meeting, Abstract 1033, 2006. |
Ernst, T et al., “Nanoscaled MOSFET Transistors on Strained Si, SiGe, Ge Layers: Some Integration and Electrical Properties Features”, ECS Trans. 2006, vol. 3, Issue 7, pp. 947-961. |
Goesele, U et al., Diffusion Engineering by Carbon in Silicon, Mat. Res. Soc. Symp. vol. 610, 2000. |
Hokazono, A et al., “Steep Channel & Halo Profiles Utilizing Boron-Diffusion-Barrier Layers (Si:C) for 32 nm Node and Beyond”, 2008 Symposium on VLSI Technology Digest of Technical Papers, pp. 112-113, 2008. |
Hokazono, A et al., “Steep Channel Profiles in n/pMOS Controlled by Boron-Doped Si:C Layers for Continual Bulk-CMOS Scaling”, IEDM09-676 Symposium, pp. 29.1.1-29.1.4, 2009. |
Holland, OW and Thomas, DK “A Method to Improve Activation of Implanted Dopants in SiC”, Oak Ridge National Laboratory, Oak Ridge, TN, 2001. |
Kotaki, H., et al., “Novel Bulk Dynamic Threshold Voltage MOSFET (B-DTMOS) with Advanced Isolation (SITOS) and Gate to Shallow-Well Contact (SSS-C) Processes for Ultra Low Power Dual Gate CMOS”, IEDM 96, pp. 459-462, 1996. |
Lavéant, P. “Incorporation, Diffusion and Agglomeration of Carbon in Silicon”, Solid State Phenomena, vols. 82-84, pp. 189-194, 2002. |
Noda, K et al., “A 0.1-μm Delta-Doped MOSFET Fabricated with Post-Low-Energy Implanting Selective Epitaxy” IEEE Transactions on Electron Devices, vol. 45, No. 4, pp. 809 -814, Apr. 1998. |
Ohguro, T et al., “An 0.18-μm CMOS for Mixed Digital and Analog Aplications with Zero-Volt-Vth Epitaxial-Channel MOSFET's”, IEEE Transactions on Electron Devices, vol. 46, No. 7, pp. 1378-1383, Jul. 1999. |
Pinacho, R et al., “Carbon in Silicon: Modeling of Diffusion and Clustering Mechanisms”, Journal of Applied Physics, vol. 92, No. 3, pp. 1582-1588, Aug. 2002. |
Robertson, LS et al., “The Effect of Impurities on Diffusion and Activation of Ion Implanted Boron in Silicon”, Mat. Res. Soc. Symp. vol. 610, 2000. |
Scholz, Ret al., “Carbon-Induced Undersaturation of Silicon Self-Interstitials”, Appl. Phys. Lett. 72(2), pp. 200-202, Jan. 1998. |
Scholz, RF et al., “The Contribution of Vacancies to Carbon Out-Diffusion in Silicon”, Appl. Phys. Lett., vol. 74, No. 3, pp. 392-394, Jan. 1999. |
Stolk, PA et al., “Physical Mechanisms of Transient Enhanced Dopant Diffusion in Ion-Implanted Silicon”, J. Appl. Phys. 81(9), pp. 6031-6050, May 1997. |
Thompson, S et al., “MOS Scaling: Transistor Challenges for the 21st Century”, Intel Technology Journal Q3′ 1998, pp. 1-19, 1998. |
Wann, C. et al., “Channel Profile Optimization and Device Design for Low-Power High-Performance Dynamic-Threshold MOSFET”, IEDM 96, pp. 113-116, 1996. |
Werner, P. et al., “Carbon Diffusion in Silicon”, Applied Physics Letters, vol. 73, No. 17, pp. 2465-2467, Oct. 1998. |
Yan, Ran-Hong et al., “Scaling the Si MOSFET: From Bulk to SOI to Bulk”, IEEE Transactions on Electron Devices, vol. 39, No. 7, Jul. 1992. |
Shao, et al., “Boron Diffusion in Silicon: The Anomalies and Control by Point Defect Engineering”, Materials Science and Engineering R: Reports, vol. 42, No. 3-4, pp. 65-114, Nov. 1, 2003. |
Banerjee, et al. “Compensating Non-Optical Effects using Electrically-Driven Optical Proximity Correction”, Proc. of SPIE vol. 7275 7275OE, 2009. |
Cheng, et al. “Extremely Thin SOI (ETSOI) CMOS with Record Low Variability for Low Power System-on-Chip Applications”, Electron Devices Meeting (IEDM), Dec. 2009. |
Cheng, et al. “Fully Depleted Extremely Thin SOI Technology Fabricated by a Novel Integration Scheme Feturing Implant-Free, Zero-Silicon-Loss, and Faceted Raised Source/Drain”, Symposium on VLSI Technology Digest of Technical Papers, pp. 212-213, 2009. |
Drennan, et al. “Implications of Proximity Effects for Analog Design”, Custom Integrated Circuits Conference, pp. 169-176, Sep. 2006. |
Hook, et al. “Lateral Ion Implant Straggle and Mask Proximity Effect”, IEEE Transactions on Electron Devices, vol. 50, No. 9, pp. 1946-1951, Sep. 2003. |
Hori, et al., “A 0.1 μm CMOS with a Step Channel Profile Formed by Ultra High Vacuum CVD and In-Situ Doped Ions”, Proceedsing of the International Electron Devices Meeting, New York, IEEE, US, pp. 909-911, Dec. 5, 1993. |
Matshuashi, et al. “High-Performance Double-Layer Epitaxial-Channel PMOSFET Compatible with a Single Gate CMOSFET”, Symposium on VLSI Technology Digest of Technical Papers, pp. 36-37, 1996. |
Sheu, et al. “Modeling the Well-Edge Proximity Effect in Highly Scaled MOSFETs”, IEEE Transactions on Electron Devices, vol. 53, No. 11, pp. 2792-2798, Nov. 2006. |
Komaragiri, R. et al., “Depletion-Free Poly Gate Electrode Architecture for Sub 100 Nanometer CMOS Devices with High-K Gate Dielectrics”, IEEE IEDM Tech Dig., San Francisco CA, 833-836, Dec. 13-15, 2004. |
Samsudin, K et al., “Integrating Intrinsic Parameter Fluctuation Description into BSIMSOI to Forecast sub-15nm UTB SOI based 6T SRAM Operation”, Solid-State Electronics (50), pp. 86-93, 2006. |
Wong, H et al., “Nanoscale CMOS”, Proceedings of the IEEE, Vo. 87, No. 4, pp. 537-570, Apr. 1999. |